Perinatal Marijuana Use: What Every Parent Needs to Know About Cannabis and Child Development
"Explore the facts, separate the myths, and learn how cannabis use during pregnancy and lactation can impact your child's future."
The conversation around cannabis is rapidly evolving. With increasing acceptance and legalization, it's easy to overlook potential risks, especially for vulnerable populations like pregnant women and developing children. While some promote cannabis as a safe alternative for managing pain or reducing opioid dependence, the reality is more complex.
It's essential to understand that cannabis isn't a benign substance, particularly during critical developmental stages. The psychoactive component, THC, readily crosses the placental barrier and can impact a child's neurodevelopment. So, let's delve into the facts and address the concerns surrounding perinatal marijuana use.
This article aims to clarify the potential risks associated with cannabis use during pregnancy and lactation. By providing a clear understanding of the science, we hope to empower parents to make informed decisions about their health and their children's well-being. This information is inspired by the JAMA Viewpoint article: Perinatal Marijuana Use and the Developing Child.
Current Use and Outcomes
Pooled 2021-2023 National Survey on Drug Use and Health data included 1,992 pregnant participants and examined current, recent, former, and never cannabis use. The same NSDUH period produced an estimate of past-month cannabis use among 6.8% of pregnant respondents. A prior meta-analysis found that associations with low birthweight and preterm delivery disappeared after adjustment for prenatal tobacco use, although most studies predated state-level recreational cannabis legalization.
Clinical Guidance and Evidence Limits
ACOG guidance is intended to help obstetrician-gynecologists and other health professionals counsel, screen, and develop strategies to reduce cannabis use before pregnancy and during pregnancy and lactation. A recent review reports associations between cannabis use during pregnancy and increased risks of preterm birth, low birthweight, and NICU admission. These recommendations and findings support clinical attention, while the review format reflects an evidence base that continues to require careful interpretation.
An Evolving Evidence Base
The evidence surrounding cannabis use during pregnancy has developed over time as researchers have examined maternal, perinatal, neonatal, and child-development outcomes. Earlier findings may not fully reflect the current legal and product landscape, particularly as cannabis use and potency have changed. Historical comparisons therefore require caution because study methods, exposure patterns, and surrounding conditions may differ.
How Does Marijuana Affect Fetal Development?
THC, the primary psychoactive component in marijuana, poses a direct threat to a developing fetus. It readily crosses the placental barrier, exposing the baby's delicate brain to its effects. This exposure can disrupt the crucial endocannabinoid system, which plays a pivotal role in: fetal and postnatal brain development, neuronal connectivity, glial cell differentiation.
- Brain Development Disruption: THC can interfere with the formation of neural pathways and brain structures, potentially impacting cognitive function later in life.
- Neurotransmitter Imbalance: The proper function of dopamine, opioid, glutamate, and GABAergic systems can be altered, affecting mood, reward processing, and stress response.
- Epigenetic Changes: Prenatal cannabis exposure may even lead to epigenetic modifications, impacting future generations.
Recent Evidence on Prenatal Exposure
A 2025 review examined available evidence on prenatal cannabis exposure and adverse health outcomes in neonates and early childhood. A separate study investigated antenatal cannabis use in relation to fetal growth, preterm birth, and other perinatal outcomes. Together, these publications show that current research is addressing both immediate perinatal outcomes and possible effects during early childhood.
Limits of Current Studies
A systematic review reported greater odds of preterm birth, small-for-gestational-age birth, and perinatal mortality after accounting for prenatal tobacco use. However, the review emphasized that confidence in these findings was limited. Many existing studies did not adequately capture the timing or quantity of cannabis use, making it difficult to determine how exposure patterns affect risk.
Guidance Across Perinatal Stages
ACOG's clinical consensus addresses cannabis use across prepregnancy, pregnancy, and lactation. It is directed toward obstetrician-gynecologists and other health care professionals who counsel and screen patients or help reduce cannabis use. This stage-spanning approach treats cannabis counseling as relevant before conception as well as during pregnancy and breastfeeding.
The Bottom Line: Consistent Advice is Crucial
Given the potential risks, the most responsible course of action is to abstain from cannabis use during pregnancy and lactation. Medical professionals should provide consistent advice, emphasizing the importance of avoiding THC exposure to protect the developing child. For women struggling with cannabis use disorder (CUD), accessible and tailored treatment programs are essential, especially during pregnancy and postpartum. Further, both women and men caring for developing children should maintain abstinence.
Assessing Perinatal Risk
The cited study was designed to determine whether maternal cannabis use during pregnancy increases the odds of perinatal morbidity and mortality. Its central focus is therefore the relationship between exposure and adverse outcomes around the time of birth. The study's stated objective does not, by itself, establish the magnitude or certainty of any association.
A Changing Cannabis Landscape
The cannabis landscape is changing rapidly, with over 40% of adults aged 19 to 30 years reported to have used cannabis in the past year. The source identifies the rising prevalence of cannabis use among pregnant women as a major concern. Future research and policy will need to account for this changing pattern of use and its implications for maternal and child health.
Patient Perspectives and Health Context
A study of pregnant people's perspectives notes that potential negative health effects of cannabis use may remain relevant both within and outside pregnancy. It also identifies evidence associating cannabis use with anemia in pregnant people. These findings place cannabis counseling within the broader context of maternal health rather than limiting the discussion to fetal outcomes.
Uncertainty for Families
Research on cannabis use during pregnancy has examined outcomes for mothers and infants, but uncertainty remains about pregnancy complications and later-life outcomes for offspring. A 2024 study likewise described the association between prenatal cannabis use and maternal health as complex. Both sources support the need for continued research rather than simple conclusions about every individual's outcome.